Charles Schwab
NTUS

Charles Schwab’s Natus Medical Inc NTUS Stock Holding History

Charles Schwab’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-354,923
Closed -$11.6M – 3598
2022
Q2 		$11.6M Sell
354,923
-86,203
-20% -$2.72M ﹤0.01% 1756
2022
Q1 		$11.6M Buy
441,126
+20,320
+5% +$496K ﹤0.01% 1867
2021
Q4 		$9.99M Buy
420,806
+33,351
+9% +$823K ﹤0.01% 2005
2021
Q3 		$9.72M Buy
387,455
+73,884
+24% +$1.88M ﹤0.01% 2024
2021
Q2 		$8.15M Buy
313,571
+24,259
+8% +$660K ﹤0.01% 2107
2021
Q1 		$7.41M Sell
289,312
-8,996
-3% -$231K ﹤0.01% 2105
2020
Q4 		$5.98M Sell
298,308
-1,511
-0.5% -$29.6K ﹤0.01% 2134
2020
Q3 		$5.14M Sell
299,819
-12,978
-4% -$245K ﹤0.01% 2045
2020
Q2 		$6.83M Sell
312,797
-54,896
-15% -$1.26M ﹤0.01% 1877
2020
Q1 		$8.51M Sell
367,693
-20,877
-5% -$607K 0.01% 1544
2019
Q4 		$12.8M Buy
388,570
+35,434
+10% +$1.14M 0.01% 1516
2019
Q3 		$11.2M Buy
353,136
+49,460
+16% +$1.44M 0.01% 1529
2019
Q2 		$7.8M Buy
303,676
+49,335
+19% +$1.26M ﹤0.01% 1746
2019
Q1 		$6.46M Buy
254,341
+70,940
+39% +$2.12M ﹤0.01% 1849
2018
Q4 		$6.24M Sell
183,401
-430
-0.2% -$14K ﹤0.01% 1765
2018
Q3 		$6.55M Buy
183,831
+8,117
+5% +$287K ﹤0.01% 1899
2018
Q2 		$6.06M Buy
175,714
+15,684
+10% +$550K ﹤0.01% 1905
2018
Q1 		$5.39M Buy
160,030
+10,289
+7% +$326K ﹤0.01% 1899
2017
Q4 		$5.72M Sell
149,741
-12,821
-8% -$512K ﹤0.01% 1862
2017
Q3 		$6.1M Sell
162,562
-3,366
-2% -$119K 0.01% 1768
2017
Q2 		$6.19M Sell
165,928
-29,237
-15% -$1.06M 0.01% 1681
2017
Q1 		$7.66M Buy
195,165
+15,175
+8% +$569K 0.01% 1493
2016
Q4 		$6.26M Buy
179,990
+53,005
+42% +$2.08M 0.01% 1587
2016
Q3 		$4.99M Buy
126,985
+10,372
+9% +$414K 0.01% 1656
2016
Q2 		$4.41M Buy
116,613
+1,908
+2% +$63.9K 0.01% 1646
2016
Q1 		$4.41M Buy
114,705
+2,190
+2% +$81.6K 0.01% 1588
2015
Q4 		$5.41M Buy
112,515
+4,508
+4% +$209K 0.01% 1464
2015
Q3 		$4.26M Sell
108,007
-9,501
-8% -$404K 0.01% 1580
2015
Q2 		$5M Sell
117,508
-9,433
-7% -$376K 0.01% 1543
2015
Q1 		$5.01M Buy
126,941
+7,037
+6% +$259K 0.01% 1507
2014
Q4 		$4.32M Buy
119,904
+35,050
+41% +$1.18M 0.01% 1550
2014
Q3 		$2.5M Buy
84,854
+6,696
+9% +$185K ﹤0.01% 1830
2014
Q2 		$1.97M Sell
78,158
-496
-0.6% -$12.3K ﹤0.01% 1993
2014
Q1 		$2.03M Buy
78,654
+5,960
+8% +$150K ﹤0.01% 1949
2013
Q4 		$1.64M Buy
72,694
+322
+0.4% +$6.22K ﹤0.01% 2033
2013
Q3 		$1.05M Buy
72,372
+886
+1% +$11.8K ﹤0.01% 2192
2013
Q2 		$998K Buy
+71,486
New +$974K ﹤0.01% 2163

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Charles Schwab's NTUS Position: Q3 2022 in Review

Charles Schwab sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 354,923 shares — an estimated $11.6M sold.

Charles Schwab first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $12.8M in Q4 2019. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Charles Schwab reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Charles Schwab sold 354,923 Natus Medical Inc shares in Q3 2022, an estimated $11.6M.
  • Charles Schwab first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
  • Charles Schwab's Natus Medical Inc position peaked at $12.8M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.